# Allogene Therapeutics funding: rounds and investors > Allogene Therapeutics has raised $310M across 2 rounds since 2024. Investors include Perceptive Advisors, TPG and Franklin Templeton. Source: https://millionrounds.com/company/allogene-therapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Allogene Therapeutics* 2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Raised 7 months ago Funding summary Updated 26 Oct 2026 **$310M** raised across 2 rounds since 2024, from 2 sources **$110M** Round **$200M** Round - **Latest round:** Round, $200M Apr 2026 - **Step-up i:** 1.8× - **Investors:** 3 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2025 2026 **$110M** Round **$200M** Round - **First round:** Round, $110M - **Biggest round:** $200M - **Between rounds:** 23 months ## The rounds - **Apr 2026** Round **$200M** *3 returning* [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [TPG](https://millionrounds.com/fund/tpg) [Franklin Templeton](https://millionrounds.com/fund/franklin-templeton) Source recorded - **May 2024** Round **$110M** *3 new* [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [TPG](https://millionrounds.com/fund/tpg) [Franklin Templeton](https://millionrounds.com/fund/franklin-templeton) Source recorded ## Founders and team From Allogene Therapeutics's own website and the SEC filings it signed: 5 on the team. - **Susie Lundeen** Chief People Officer - **Earl Douglas** General Counsel - **In Memoriam** David Bonderman, Lead Independant Director of Allogene - **David M. Tanen** Executive Officer i - **Joshua A. Kazam** Executive Officer, Director i On the board, as filed i *Arie M. Belldegrun* *David M. Bonderman* *David M. Chang* *Franz M. Humer* *Owen M. Witte* *Robert M. Abraham* *Todd M. Sisitsky* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Round** 2024 **Round** 2026 [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) [TPG](https://millionrounds.com/fund/tpg) [Franklin Templeton](https://millionrounds.com/fund/franklin-templeton) ## Everyone who backed them [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) Asset manager **2** rounds [TPG](https://millionrounds.com/fund/tpg) Private equity **2** rounds [Franklin Templeton](https://millionrounds.com/fund/franklin-templeton) Private equity **2** rounds Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=allogene-therapeutics). ## Also claim to have backed them This firm lists Allogene Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Avoro Capital Advi...](https://millionrounds.com/fund/avoro-capital-advi) Private equity Per its own site ## Quick answers about Allogene Therapeutics ### Who invested in Allogene Therapeutics? Allogene Therapeutics's investors include Perceptive Advisors, TPG and Franklin Templeton. ### How much has Allogene Therapeutics raised? Allogene Therapeutics has raised $310M across 2 rounds since 2024. ### When did Allogene Therapeutics last raise? Allogene Therapeutics's most recent round was an Undisclosed round of $200M in Apr 2026. ### What was Allogene Therapeutics's biggest round? Its most recent round, $200M in Apr 2026, is also its largest on record. ### Who backed Allogene Therapeutics first? Allogene Therapeutics's first round on record, in May 2024, was backed by Perceptive Advisors, TPG and Franklin Templeton. ### What stage is Allogene Therapeutics at? Allogene Therapeutics's latest named round is an Undisclosed round, in Apr 2026. ### Where is Allogene Therapeutics based? Allogene Therapeutics is based in the United States. ## Companies like Allogene Therapeutics In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app